---
schema_version: "secwatch.filing_event.v1"
accession: "0001472375-24-000106"
form_type: "8-K"
ticker: "RGPX"
cik: "0001357878"
company_name: "REGENEREX PHARMA, INC."
filed_at: "2024-12-10T23:59:59+00:00"
generated_at: "2026-05-29T05:06:59.727547+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# RegeneRx Pharma announces CFO resignation and appointments of new CFO, Secretary, and board member

## Summary
- Deborah Pilant resigned as CFO, Secretary/Treasurer, and board director effective Dec 6, 2024, due to retirement.
- Brent Wilson appointed CFO; CPA with 30 years experience, previously at KPMG, effective Dec 6, 2024.
- Dr. Lee Ori appointed Secretary/Treasurer for the coming year; currently serves as a board director.
- J. Kenneth Hazen appointed to the board; President/CEO of CTSI-Global, recognized in logistics and supply chain.

## SEC filing metadata
- accession: 0001472375-24-000106
- form_type: 8-K
- ticker: RGPX
- cik: 0001357878
- company_name: REGENEREX PHARMA, INC.
- filed_at: 2024-12-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357878/000147237524000106/0001472375-24-000106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357878/000147237524000106/ixform8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001472375-24-000106
- JSON: https://secwatch.observer/filing/0001472375-24-000106.json
- Plain text: https://secwatch.observer/filing/0001472375-24-000106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.